147PD A PHASE II STUDY OF WEEKLY PACLITAXEL PLUS GEMCITABINE AS SECOND-LINE THERAPY IN PATIENTS WITH METASTATIC OR RECURRENT SMALL CELL LUNG CANCER (SCLC)

✍ Scribed by Kim, H.T.; Yun, T.; Han, J.; Choi, H.L.; Kim, H.Y.; Lee, J.S.

• Book ID: 118574446
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 42 KB
• Volume: 64
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/s0169-5002(09)70270-3